These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22023618)

  • 1. Cognitive impairment with vascular impairment and degeneration.
    Pluta R; Jolkkonen J; Cuzzocrea S; Pedata F; Cechetto D; Popa-Wagner A
    Curr Neurovasc Res; 2011 Nov; 8(4):342-50. PubMed ID: 22023618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide.
    Pluta R; Jabłoński M; Czuczwar SJ
    Folia Neuropathol; 2012; 50(2):101-9. PubMed ID: 22773455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    Anderson M; Xu F; Ou-Yang MH; Davis J; Van Nostrand WE; Robinson JK
    J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly.
    Daulatzai MA
    J Neurosci Res; 2015 Dec; 93(12):1778-94. PubMed ID: 26301370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
    Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
    Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ
    Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L
    Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.
    Salminen A; Kauppinen A; Kaarniranta K
    J Neurochem; 2017 Feb; 140(4):536-549. PubMed ID: 27987381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease.
    Pluta R
    Ann N Y Acad Sci; 2000 Apr; 903():324-34. PubMed ID: 10818522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology of cognitive disorders.
    Kurz A; Perneczky R
    Curr Opin Psychiatry; 2009 Nov; 22(6):546-51. PubMed ID: 19644374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
    Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
    Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.